EWEdwards Lifesciences
Edwards Lifesciences Corporation is the leading global structural heart innovation company, driven by a passion to improve patient lives. 10-K, Item 1
- Employees
- 16,000
- Headquarters
- Irvine, CA
- CEO
- Bernard J. Zovighian
- Next results
- around Feb 9, 2027
From 2021 to 2025, CEO pay as reported rose 28% while net income fell 30%. $100 in the shares at the start of the table was worth $93 at the end (peer group: $127). CEO pay over the 5 years: $74.3M.
| Fiscal year to | CEO | CEO pay (reported) | CEO pay (actually paid) | Other executives, average | $100 became | Peer group | Net income | •underlying revenue growth |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | - | $17.5M | $21.3M | $4.7M | $93 | $127 | $1.1B | 0.107 |
| Dec 31, 2024 | - | $14.6M | $9.2M | $4.4M | $81 | $117 | $1.4B | 0.089 |
| Dec 31, 2023 | - | $14.7M | $6.8M | $5.0M | $84 | $106 | $1.4B | 0.121 |
| Dec 31, 2022 | - | $14.0M | -$10.5M | $4.2M | $82 | $97 | $1.5B | 0.077 |
| Dec 31, 2021 | - | $13.6M | $31.5M | $3.5M | $142 | $119 | $1.5B | 0.178 |
Pay versus performance table of the proxy statement (DEF 14A) filed Mar 26, 2026, as tagged by the company in XBRL. Open the proxy ↗
Work on EW in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/EW/export.csv") into a cell.